Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2019-04-17 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
2018年年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and compliance of the 2018 Annual General Meeting (AGM) of Zhengzhou Antu Bioengineering Co., Ltd. It details the convening, attendance, voting procedures, and results of the AGM. The document does not contain financial statements or detailed financial performance data but focuses on the procedural and legal aspects of the AGM. This fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document length is about 5,085 characters, which is sufficient for a detailed legal opinion but not a full annual report or audit report. Therefore, the correct classification is AGM Information (AGM-R).
2019-04-17 Chinese
关于二级子公司完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of a business registration change for a subsidiary. It includes details about the subsidiary's new business license and updated business scope. There is no financial data, no mention of financial results, no regulatory certifications, or voting results. It is not a report or presentation but a regulatory announcement about corporate administrative changes. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-04-15 Chinese
与招商证券关于《郑州安图生物工程股份有限公司公开发行A股可转换公司债券申请文件反馈意见的回复》（修订稿）
Audit Report / Information Classification · 95% confidence The document is a detailed response to feedback from the China Securities Regulatory Commission regarding an application for the public issuance of A-share convertible bonds by Zhengzhou Antu Bioengineering Co., Ltd. It includes extensive disclosures about administrative penalties, production qualifications, product quality control, and goodwill accounting related to a recent acquisition. The content is focused on regulatory compliance, financial and operational disclosures, and audit-related confirmations. The document is lengthy (15,000 characters) and contains substantive financial and operational data, not merely an announcement or certification. It is not a full annual or interim report but is closely related to regulatory review and audit feedback on a financing application. Given the detailed audit confirmations, accounting discussions, and regulatory compliance focus, this document fits best under the category of Audit Report / Information (AR), which includes standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. 9M 2018
2019-04-10 Chinese
关于公开发行可转换公司债券申请文件反馈意见回复修订的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhengzhou Antu Bioengineering Co., Ltd. regarding the feedback and revised responses to the China Securities Regulatory Commission (CSRC) on their application for public issuance of convertible bonds. It mentions the review process, submission of reply materials, and approval by the CSRC's issuance review committee, but it does not contain actual financial statements or detailed financial data. The document is relatively short (848 characters) and serves as a disclosure update on the application and regulatory feedback process related to financing activities. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to the company's capital raising through convertible bonds and regulatory approval updates.
2019-04-10 Chinese
2018年度股东大会文件
AGM Information Classification · 95% confidence The document is titled as "2018年度股东大会会议材料" which translates to "2018 Annual General Meeting (AGM) Meeting Materials". It contains detailed agenda items for the AGM, including reports from the board of directors, supervisory board, financial reports, profit distribution proposals, remuneration plans, audit institution appointments, and other shareholder meeting proposals. The document also includes meeting procedures, voting instructions, and legal opinions related to the AGM. The content is consistent with materials prepared and distributed for an Annual General Meeting rather than the full annual report or other filings. The document length is substantial (15,000 characters), indicating it is the meeting materials themselves, not just an announcement of the meeting or report publication. Therefore, the appropriate classification is AGM Information (AGM-R).
2019-04-08 Chinese
关于公开发行可转换公司债券申请获得中国证监会发行审核委员会审核通过的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the approval of the company's application for public issuance of convertible bonds by the China Securities Regulatory Commission's issuance review committee. It is a notification about a financing activity (issuance of convertible bonds) and does not contain financial statements or detailed financial data. The document is short and serves as an update on a capital raising process, fitting the category of Capital/Financing Update.
2019-04-04 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.